Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lapix Therapeutics Logo
Lapix Therapeutics Growth Score
76
CB Rank
64012
Heat Score
71
Lapix Therapeutics operates as an immune system modulation company.
Founded
obfuscation
PrivateVenture - Series Unknown Boston, Massachusetts, United States1-10 lapix.com
Health Care
Medical
Therapeutics
Overview

Lapix Therapeutics
Total Funding
obfuscation
Growth Score
76
Heat Score
71

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score76
-14 pts
in past quarter
Heat Score 71
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Lapix Therapeutics

CB Rank
64012
Lapix Therapeutics operates as an immune system modulation company.
Founded
obfuscation
PrivateVenture - Series Unknown Boston, Massachusetts, United States1-10 lapix.com
Health Care
Medical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Lapix Therapeutics Inc.
Operating Status Active
Company Type For Profit
Founders  Anas Fathallah
About the Company
Lapix Therapeutics operates as an immune system modulation company. It helps by targeting therapies that delay the onset of disease, sustain response, or make partner drugs safer.
Contact Email info@lapixtherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

LPX-TI641
An orally bioavailable small molecule designed as a T cell immunoglobulin and mucin domain-containing protein (Tim) 3/4 receptor agonist for treating autoimmune diseases like Multiple Sclerosis.
LPX-TIGI
A preclinical asset aimed at treating Inflammatory Bowel Disease and food allergies by modulating immune responses, specifically for conditions like Crohn’s Disease and Ulcerative Colitis.

Research & Development

Lapix Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Lapix Therapeutics Logo
Venture Round - Lapix Therapeutics
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 8

Employee Profiles

News

News and Press

News•Dec 23, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 9, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

332
16.08%
 in past month

IT Spend

$36.9KThis year, Lapix Therapeutics is projected to spend $36.9K on IT, according to Aberdeen.

Total IP

9The intellectual property of Lapix Therapeutics includes 8 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Lapix Therapeutics has 1 registered trademark in the 'Agricultural products; live animals' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Lapix Therapeutics's headquarters? Lapix Therapeutics is located in Boston, Massachusetts, United States.When was the last funding round for Lapix Therapeutics? Lapix Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Lapix Therapeutics's competitors? Alternatives and possible competitors to Lapix Therapeutics may include Abivax, Kyverna Therapeutics, and  Bristol-Myers Squibb.How much funding has Lapix Therapeutics raised to date? Lapix Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|